This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocols
暂无分享,去创建一个
Matthew R. Sydes | Noel W. Clarke | Lindsey Masters | Claire Amos | Louise Brown | Mahesh Parmar | M. Parmar | M. Sydes | N. Clarke | G. Attard | R. Kaplan | F. Hudson | S. Gillessen | Lindsey Masters | F. Schiavone | R. Langley | C. Amos | Louise Brown | Silke Gillessen | A. Bara | Fleur Hudson | N. Atako | C. Gilson | Cheryl Pugh | Francesca Schiavone | Riya Bathia | Krishna Letchemanan | Anna Bara | Clare Gilson | Nafisah Atako | Ruth Langley | Richard S. Kaplan | Chris Parker | Gert Attard | Nicholas D. James | Tim Maughan | C. Pugh | Chris Parker | R. Bathia | Timothy S. Maughan | Nicholas D James | K. Letchemanan | Gert Attard | C. Parker
[1] M. Dimairo,et al. Adaptive designs undertaken in clinical research: a review of registered clinical trials , 2016, Trials.
[2] Babak Choodari-Oskooei,et al. Measuring the impact of methodological research: a framework and methods to identify evidence of impact , 2014, Trials.
[3] Noel W Clarke,et al. Combining enzalutamide with abiraterone, prednisone, and androgen deprivation therapy in the STAMPEDE trial. , 2014, European urology.
[4] M. Sydes,et al. Repurposing Metformin as Therapy for Prostate Cancer within the STAMPEDE Trial Platform. , 2016, European urology.
[5] Sydes,et al. A proposed charter for clinical trial data monitoring committees: helping them to do their job well , 2005, The Lancet.
[6] M. Parmar,et al. Prostate radiotherapy for men with metastatic disease: a new comparison in the STAMPEDE trial. , 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).
[7] David Moher,et al. SPIRIT 2013 Statement: defining standard protocol items for clinical trials. , 2015, Revista panamericana de salud publica = Pan American journal of public health.
[8] M. Parmar,et al. Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data , 2016, The Lancet. Oncology.
[9] R. Butler,et al. Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS, and NRAS (FOCUS4-D): a phase 2-3 randomised trial , 2018 .
[10] S. Berry,et al. Efficiencies of platform clinical trials: A vision of the future , 2016, Clinical trials.
[11] R. Laing,et al. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial , 2016, The Lancet.
[12] Thomas Jaki,et al. Some recommendations for multi-arm multi-stage trials , 2012, Statistical methods in medical research.
[13] M. Sydes,et al. Transdermal oestradiol as a method of androgen suppression for prostate cancer within the STAMPEDE trial platform , 2018, BJU international.
[14] How Cancer Research UK is adapting to adaptive designs , 2011, Trials.
[15] M. Parmar,et al. More multiarm randomised trials of superiority are needed , 2014, The Lancet.
[16] J. Woodcock,et al. Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both. , 2017, The New England journal of medicine.
[17] D. Rennie,et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. , 2013, Annals of internal medicine.
[18] M. D. James,et al. Pre-trial inter-laboratory analytical validation of the FOCUS4 personalised therapy trial , 2015, Journal of Clinical Pathology.
[19] M. Parmar,et al. Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multi-arm multi-stage randomized controlled trial , 2012, Trials.
[20] M. Parmar,et al. Testing many treatments within a single protocol over 10 years at MRC Clinical Trials Unit at UCL: Multi-arm, multi-stage platform, umbrella and basket protocols , 2017, Clinical trials.
[21] D. Berry,et al. A conceptual model for the development process of confirmatory adaptive clinical trials within an emergency research network , 2017, Clinical trials.